Compounds of three-dimensional derivatives of phenylglucoamylonitrile (phenylglucose) are substituted by CO-Transport Sodio/D-Glucosa (SGLT) mediators； pharmacological synthesis； pharmacological combination； for the treatment of metabolic Sindrome, Sindrome X, diabetes, insulin resistance, etc.

• 收藏
• 分享

专利权人:

NOVARTIS AG.

发明人:

GREGORY RAYMOND BEBERNITZ

申请号：

CL2013002973

公开号：

CL2013002973A1

申请日:

2013.10.14

申请国别(地区):

CL

年份:

2014

代理人:

摘要：

The present invention provides a compound of formula I； a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.COMPUESTOS DERIVADOS DE ESTERES DE FENILGLUCOPIRANOSIL SUSTITUIDOS MEDIADORES DEL CO-TRANSPORTADOR SODIO/D-GLUCOSA (SGLT)； COMPOSICION FARMACEUTICA； COMBINACION FARMACEUTICA； Y SU USO EN EL TRATAMIENTO DEL SINDROME METABOLICO, SINDROME X, DIABETES, RESISTENCIA A LA INSULINA, ENTRE OTROS

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/